Search

339 Result(s)
Sort by

FIBRONEER™ Phase III program initiated

FIBRONEER™ Phase III program initiated

FIBRONEER™ Phase III program initiated globally to evaluate BI 1015550, a novel investigational phosphodiesterase 4B (PDE4B) inhibitor
Martin Stefanic

Martin Stefanic

Learn how Patient Safety is at the cutting edge of innovation.
Innovation from within

Innovation from within

Justine Rochon and Marc Weimer talk about the transformation of Biostatistics and Data Sciences (BDS) into a modern organisation in drug development.
Ivana Ritter

Ivana Ritter

Find out how Ivana become our Global Head of Safety.
Eugene Zalmover

Eugene Zalmover

Learn how Eugene’s work paved the way for digital innovation in Patient Safety.
Rafael Sani Simoes

Rafael Sani Simoes

Learn how Rafael’s role in Patient Safety enables him to make a difference.
Shimoli Shah

Shimoli Shah

Watch how Shimoli transitioned from practising clinician to Patient Safety Physician.
Samina Ajaz Hussain

Samina Ajaz Hussain

Discover how Samina never looked back on her career move to Patient Safety.
Translational Medicine & Clinical Pharmacology

Translational Medicine & Clinical Pharmacology

We connect the right patient with the right drug on the right dosing schedule using data science methods from pharmacometrics to systems pharmacology.
Waste

Waste

Resource conservation at Boehringer Ingelheim is managed as part of an ongoing process of prevention and reduction of material usage and waste.
Green Chemistry

Green Chemistry

Green Chemistry is critical for us as it balance the long-term sustainability of business, society, and the environment.
opening-solids-launch-fabrik

opening-solids-launch-fabrik

Boehringer Ingelheim today opened a tablet factory at Ingelheim in the presence of the State Premier of Rhineland-Palatinate, Malu Dreyer.
More Health Overview

More Health Overview

Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.